ArticleInternational journal of clinical and experimental medicine2015

The efficacy and safety of adding bevacizumab to cetuximab- or panitumumab-based therapy in the treatment of patients with metastatic colorectal cancer (mCRC): a meta-analysis from randomized control trials.

Yingqian Lv et al.PubMed ↗Full text ↗

No numbers read from the abstract.